Through validation in multi-centre cohorts and assisted by ML algorithms, we identified FIBG/PDGF-β/TGF-β-enriched EVs exhibited excellent diagnostic performance for CRC. This evidence concerns the gene TGFB1 and colorectal carcinoma.